Patents for A61P 35 - Antineoplastic agents (221,099)
12/2004
12/22/2004EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004EP1175430A4 Antisense-oligos with better stability and antisense effect
12/22/2004EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004EP1121363B1 6-SUBSTITUTED PYRAZOLO(3,4-d)PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
12/22/2004EP1080066A4 Bioreductive cytotoxic agents
12/22/2004EP0927030B1 Use of aryl n-substituted carboxamides to kill tumors
12/22/2004EP0768889B1 Cancer therapy using lymphotoxin
12/22/2004CN1556863A Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
12/22/2004CN1556853A Probiotics lactobacillus casei bacterial strain
12/22/2004CN1556828A Hydrophili polymer derirative having Y shaped branch, its preparation method, combined object with medicine molecule and medical compositon containing combined object
12/22/2004CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004CN1556807A Chemical compounds
12/22/2004CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004CN1556797A Substituted isoxazole compound and its application as antibiotics
12/22/2004CN1556716A Modular infusion device and method
12/22/2004CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004CN1556701A Tetrapeptide derivative crystals
12/22/2004CN1556221A Use of IC 53 gene and its related product in diagnosing and treating colon cancer and reagent box for diagnosing colon canter
12/22/2004CN1556111A 23 position heteroatom substituted analogue of tiger's eye rohdea saponin OSW-1 kind saponin and its synthesis method and use
12/22/2004CN1555890A Anticancer medicine containing CARF gene and its related product and its use
12/22/2004CN1555886A Brilliant bingruilin acetate solid lipid nano particle oral preparation and its preparation method
12/22/2004CN1555882A Chinese medicinal composition for treating liver cancer
12/22/2004CN1555844A Medicine for treating liver cancer and its preparation method
12/22/2004CN1555829A Chinese medicinal preparation for treating cancer
12/22/2004CN1555820A Sparganium qijia decoction for treating cancer
12/22/2004CN1555813A Compound formula chitin poly saccharid preparation
12/22/2004CN1555812A Propolis drip pill and its preparation method
12/22/2004CN1555800A Changchun ruibinda transfusion preparation and its preparation method
12/22/2004CN1555799A Fatly emulsion of camptothecin kind antitumour medicine and its preparation method
12/22/2004CN1555798A Cencer treatment containing 3-aminopyridine-2-formal thiosemicarbazide
12/22/2004CN1555797A Matrine oral slow release tablet and its preparation method
12/22/2004CN1555785A Emodin injection preparation and its preparation method
12/22/2004CN1555784A Calcium alginate/polyhistidine medicine controlled release micro capsule and its manufacturing method
12/22/2004CN1181100C Inokopolyose derivative and its preparing process and application
12/22/2004CN1181096C Cyclic hexapeptide somatostatin analogues
12/22/2004CN1181092C Conjugates useful in treatment of prostate cancer
12/22/2004CN1181070C Urea substituted imidazoquinolines
12/22/2004CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004CN1181062C 2-phenoxy pyrimidine derivative and its use in treating disease
12/22/2004CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004CN1180836C Cat ginseng injection liquid and its preparation method
12/22/2004CN1180828C Chinese patent medicine for treating mastoncus
12/22/2004CN1180815C Tumor treating medicine
12/22/2004CN1180811C Chinese medicine composition for treating tumor
12/22/2004CN1180788C Process for preparing heterogenous phaeochrome cell microcapsule
12/21/2004US6833480 Useful in inhibiting proliferation of and/or killing cancer cells
12/21/2004US6833456 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
12/21/2004US6833453 As an example, manufacturing a 5-(tert-butylcarbamoyl)-amino-methyl-oxazolidinone by condensing a carbamate with a tert-butylcarbamoyl protected derivative of glycidylamine or a 3-amino-1-halopropanol
12/21/2004US6833451 Lipopolysaccharides (LPS) extracted from Escherichia coli
12/21/2004US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004US6833379 As diuretic agent
12/21/2004US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/21/2004US6833367 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
12/21/2004US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004US6833355 Use of protein H as cytostatic agent
12/21/2004US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004US6833349 Therapy for skin disorders; psoriasis
12/21/2004US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/21/2004CA2317604C Matrix metalloprotease inhibitors
12/21/2004CA2140649C Hybrid oligonucleotide phosphorothioates
12/16/2004WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
12/16/2004WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004WO2004108764A2 Connective tissue growth factor antibodies
12/16/2004WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004WO2004108723A1 4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors
12/16/2004WO2004108716A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/16/2004WO2004108715A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
12/16/2004WO2004108714A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
12/16/2004WO2004108711A1 Pyrazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004WO2004108710A1 4-pyrimidinyl quinazoline derivatives for use in the treatment of tumours
12/16/2004WO2004108708A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/16/2004WO2004108707A1 Pyridazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004WO2004108704A1 Pyrimidin-4-yl 3-cyanoquinoline derivatives for use in the treatment of tumours
12/16/2004WO2004108703A1 Pyrazinyl 3-cyanoquinoline derivatives for use in the treatment of tumours
12/16/2004WO2004108702A1 Indole derivatives with apoptosis-inducing effect
12/16/2004WO2004108698A1 Process for producing cyclic lactic acid oligomer having two-fold polymerization degree
12/16/2004WO2004108683A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
12/16/2004WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004WO2004108664A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
12/16/2004WO2004108661A1 Amidino compounds as cysteine protease inhibitors
12/16/2004WO2004108654A1 Chain lactic acid oligomer derivative and process for producing the same
12/16/2004WO2004108153A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds
12/16/2004WO2004108147A1 Pharmaceutical active ingredient
12/16/2004WO2004108145A1 Therapeutical composition containing dentritic cells and use thereof
12/16/2004WO2004108144A1 Cell-containing preparations
12/16/2004WO2004108142A2 Inhibitors of tip-1 for treatment tissue damage
12/16/2004WO2004108139A2 Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
12/16/2004WO2004108136A1 Triazolo `1 , 5-a!pyrimidines and their use in medicine
12/16/2004WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
12/16/2004WO2004096224A3 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis